Expression of concern
The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies
Paper Information
Record ID:
41687
Author(s):
Publication Date:
January 30, 2018
Retraction Date:
December 30, 2022
(2.9 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0279960Citations (90)
90
Total Citations41
Post-Retraction(45.6%)
48
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
2
Within 30 days
12
Within 1 year
7
After 2+ years
901
Days since retraction (latest)
Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study
Ilias P. Nikas, Chul Lee, Min Ji Song et al. (5 authors)
Cancer Medicine
Open Access
Published: Feb 2022
7 citations
7 citations
308 days before retraction
Kinome-Wide Profiling Identifies Human WNK3 as a Target of Cajanin Stilbene Acid from Cajanus cajan (L.) Millsp.
Nadire Özenver, Onat Kadioglu, Yujie Fu et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2022
3 citations
3 citations
336 days before retraction
Network controllability solutions for computational drug repurposing using genetic algorithms
Victor Popescu, Krishna Kanhaiya, Iulian Năstac et al. (5 authors)
Scientific Reports
Open Access
Published: Jan 2022
7 citations
7 citations
338 days before retraction
Ovarian Cancer Biomarkers
Ece Gümüşoğlu-Acar, Tuba Günel
Springer eBooks
Published: Jan 2022
3 citations
3 citations
363 days before retraction
Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
Racheal Johnson, Michele Cummings, Amudha Thangavelu et al. (6 authors)
Cancers
Open Access
Published: Dec 2021
28 citations
28 citations
384 days before retraction
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
Gabriel Osborn, Chara Stavraka, Rebecca Adams et al. (12 authors)
Clinical & Experimental Immunology
Open Access
Published: Nov 2021
15 citations
15 citations
403 days before retraction
The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers
Edward Henderson, Gabriel T. Huynh, Kirsty Wilson et al. (5 authors)
Biomedicines
Open Access
Published: Oct 2021
6 citations
6 citations
428 days before retraction
A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer
Daniel A. Vallera, Felix Oh, Behiye Kodal et al. (7 authors)
Cancers
Open Access
Published: Aug 2021
33 citations
33 citations
509 days before retraction
Expression of HER2/neu Receptor in Epithelial Ovarian Cancers: An Immunohistochemical Pilot Study in Central India
Vandna Yadav, Abhay Vilas Deshmukh, V. Hari Kumar et al. (4 authors)
Indian Journal of Gynecologic Oncology
Published: Jul 2021
1 citation
1 citation
520 days before retraction
Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes
Shayantan Banerjee, Karthik Raman, Balaraman Ravindran
Cancers
Open Access
Published: May 2021
6 citations
6 citations
595 days before retraction
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Axel Hyrenius‐Wittsten, Su Yang, Minhee Park et al. (9 authors)
Science Translational Medicine
Open Access
Published: Apr 2021
179 citations
179 citations
611 days before retraction
Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer
Xibo Zhao, Shanshan Cong, Qiuyan Guo et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Apr 2021
2 citations
2 citations
616 days before retraction
Sequence neighborhoods enable reliable prediction of pathogenic mutations in cancer genomes
Shayantan Banerjee, Karthik Raman, Balaraman Ravindran
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
687 days before retraction
The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers
Khalid El Bairi, Ouissam Al Jarroudi, Saïd Afqir
Springer eBooks
Published: Jan 2021
728 days before retraction
An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein–Protein Interaction Networks in Female-Specific Cancers
Katia Pane, Ornella Affinito, Mario Zanfardino et al. (7 authors)
Frontiers in Genetics
Open Access
Published: Dec 2020
7 citations
7 citations
757 days before retraction
EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
Mayada Farrag, Ziad Emarah, Waleed Elrefaie et al. (6 authors)
Research in Oncology
Open Access
Published: Nov 2020
3 citations
3 citations
762 days before retraction
An Overview of Ovarian Cancer: Molecular Processes Involved and Development of Target-based Chemotherapeutics
Basheerulla Shaik, Tabassum Zafar, K. Balasubramanian et al. (4 authors)
Current Topics in Medicinal Chemistry
Published: Nov 2020
27 citations
27 citations
777 days before retraction
HER2/neu and Ki-67 as prognostic factors in serous type ovarian carcinoma
I Gusti Ayu Sri Mahendra Dewi, Anak Agung Ayu Ngurah Susraini, Ni Putu Ekawati
Bali Medical Journal
Open Access
Published: Oct 2020
5 citations
5 citations
819 days before retraction
The Potential Usefulness of <sup>99m</sup>Tc-HYNIC-(Ser)<sub>3</sub>-LTVPWY Peptide for Predicting HER2 Status Alteration After Chemotherapy in Ovarian Tumor-Bearing Mice
Zahra Avan, Javad Biabani Ardakani, Fereshteh Talebpour Amiri et al. (5 authors)
Cancer Biotherapy and Radiopharmaceuticals
Published: Sep 2020
3 citations
3 citations
843 days before retraction
Investigation of HER-2 expression and its Correlation with clinicopathological parameters and overall survival of esophageal squamous cell carcinoma patients
Mitra Heidarpour, M. Taheri, Ali Akhavan et al. (5 authors)
Iranian journal of pathology
Open Access
Published: Sep 2020
5 citations
5 citations
845 days before retraction
Virus-Mimicking Nanoparticles for Targeted Near Infrared Fluorescence Imaging of Intraperitoneal Ovarian Tumors in Mice
Raviraj Vankayala, Edver Bahena, Yadir Guerrero et al. (7 authors)
Annals of Biomedical Engineering
Published: Aug 2020
9 citations
9 citations
876 days before retraction
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
Olivia D. Lara, Emine Bayraktar, Paola Amero et al. (14 authors)
Oncotarget
Open Access
Published: Jul 2020
7 citations
7 citations
892 days before retraction
Kinome scale profiling of venom effects on cancer cells reveals potential new venom activities
Danielle J. McCullough, Cristina Atofanei, Emily Knight et al. (5 authors)
Toxicon
Published: Jul 2020
4 citations
4 citations
896 days before retraction
A study of her-2/ neu oncogene expression in benign and malignant ovarian tumors
Sumit Gupta, Dr Manju Mehra, Jyotsana Khattri et al. (4 authors)
International Journal of Medical Research and Review
Open Access
Published: Apr 2020
974 days before retraction
The Wnt3a/β-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab
Guodong Shen, Qian Gao, Fenfen Liu et al. (17 authors)
Biochemical and Biophysical Research Communications
Open Access
Published: Apr 2020
11 citations
11 citations
1001 days before retraction
Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
Nina Maenhoudt, Charlotte Defraye, Matteo Boretto et al. (15 authors)
Stem Cell Reports
Open Access
Published: Apr 2020
151 citations
151 citations
1003 days before retraction
Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
Britt Erickson, Burak Zeybek, Alessandro D. Santin et al. (4 authors)
Current Opinion in Obstetrics & Gynecology
Open Access
Published: Dec 2019
39 citations
39 citations
1114 days before retraction
The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas
Csongor György Lengyel, S.C. Altuna, Baker Shalal Habeeb et al. (5 authors)
Current Drug Targets
Published: Nov 2019
23 citations
23 citations
1134 days before retraction
Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality
Md. Ali Hossain, Sheikh Mohammed Shariful Islam, Julian M.W. Quinn et al. (5 authors)
Journal of Biomedical Informatics
Open Access
Published: Oct 2019
68 citations
68 citations
1164 days before retraction
Recognition Sites for Cancer-targeting Drug Delivery Systems
Siyu Guan, Qianqian Zhang, Jianwei Bao et al. (6 authors)
Current Drug Metabolism
Published: Oct 2019
5 citations
5 citations
1184 days before retraction
Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†
David P. Cook, Barbara C. Vanderhyden
Biology of Reproduction
Published: Jun 2019
42 citations
42 citations
1298 days before retraction
Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
So Young Kim, Kyung Un Choi, Chungsu Hwang et al. (12 authors)
Journal of Pathology and Translational Medicine
Open Access
Published: May 2019
6 citations
6 citations
1338 days before retraction
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
Elisa Schmoeckel, Sophie Hofmann, Daniel Fromberger et al. (10 authors)
Virchows Archiv
Published: Feb 2019
21 citations
21 citations
1422 days before retraction
Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer
Garam Kım, Poshan Yugal Bhattarai, Hong Seok Choi
Archives of Pharmacal Research
Published: Jan 2019
9 citations
9 citations
1435 days before retraction
Overexpression of HER2/HER3 and clinical feature of ovarian cancer
Ye Won Chung, Seongmin Kim, Jin Hwa Hong et al. (7 authors)
Journal of Gynecologic Oncology
Open Access
Published: Jan 2019
54 citations
54 citations
1459 days before retraction
Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma
Sho Yoshimoto, Daiki Kato, Satoshi Kamoto et al. (16 authors)
Journal of Veterinary Medical Science
Open Access
Published: Jan 2019
20 citations
20 citations
1459 days before retraction
Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer
Quan Zhou, Chao-Nan Hou, Huai-jie Yang et al. (5 authors)
Cancer Management and Research
Open Access
Published: Dec 2018
7 citations
7 citations
1490 days before retraction
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
Wenna Guo, Liucun Zhu, Minghao Yu et al. (6 authors)
Clinical Epigenetics
Open Access
Published: Nov 2018
48 citations
48 citations
1505 days before retraction
Prognostic Effect of Bisphosphonate Exposure for Patients With Diagnosed Solid Cancer: A Systematic Review With Meta-Analysis of Observational Studies
Danting Wen, Zheng Xu, Meiling Xuan et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Oct 2018
6 citations
6 citations
1523 days before retraction
Role of Her-2 Neu as Prognostic Indicator in Surface Epithelial Tumors of Ovary
B. Krishnaswamy
Journal of Medical Science And clinical Research
Open Access
Published: Oct 2018
2 citations
2 citations
1525 days before retraction
Quick Stats
Total Citations:
90
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025